Clinical discussions in antithrombotic therapy management : a delphi consensus panel
نویسندگان
چکیده
منابع مشابه
Performance indicators for clinical practice management in primary care in Portugal: consensus from a Delphi study.
BACKGROUND Performance indicators assessing the quality of medical care and linked to pay for performance may cause disagreement. Portuguese indicators included in recent health care reform are controversial. OBJECTIVES To obtain consensus from opinion leaders in family medicine regarding the performance indicators for practice management used in the evaluation of Family Health Units in Portu...
متن کاملPerioperative management of antithrombotic therapy.
The management of patients who require temporary interruption of warfarin therapy because of elective surgery or another invasive procedures is clinically important because of the increasing prevalence of patients who are receiving warfarin and the availability of low-molecular-weight heparins, which facilitate out-of-hospital perioperative anticoagulation. The two main issues that need to be c...
متن کاملFocal Therapy in Prostate Cancer—Report from a Consensus Panel
Purpose: To establish a consensus in relation to case selection, conduct of therapy, and outcomes that are associated with focal therapy for men with localized prostate cancer. Material and Methods: Urologic surgeons, radiation oncologists, radiologists, and histopathologists from North America and Europe participated in a consensus workshop on focal therapy for prostate cancer. The consensus p...
متن کاملFocal therapy in prostate cancer-report from a consensus panel.
PURPOSE To establish a consensus in relation to case selection, conduct of therapy, and outcomes that are associated with focal therapy for men with localized prostate cancer. MATERIAL AND METHODS Urologic surgeons, radiation oncologists, radiologists, and histopathologists from North America and Europe participated in a consensus workshop on focal therapy for prostate cancer. The consensus p...
متن کاملSummary of Panel Discussions
Introduction During the Workshop "Pharmacokinetics: Defining the Dose for Risk Assessment," two panel discussions were held. The first was "Design of Studies to Obtain Pharmacokinetic Data for Risk Assessment." Emil Pfitzer of HoffmannLa Roche, Inc.; James Stevens of Ciba-Geigy Corporation;Penelope FennerCrisp of the U.S. Environmental Protection Agency Pesticides Program; and Daniel Menzel of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Atrial Fibrillation
سال: 2020
ISSN: 1941-6911
DOI: 10.4022/jafib.2159